Ofatumumab (Arzerra, HuMax-CD20)


Indications


Pharmacology

Metabolism


Administration

Dose Adjustment


Adverse Effects

Infectious Adverse Effects

Hepatitis B Reactivation (see Hepatitis B Virus, [[Hepatitis B Virus]])

Progressive Multifocal Encephalopathy (PML) (see Progressive Multifocal Leukoencephalopathy, [[Progressive Multifocal Leukoencephalopathy]])

Other Adverse Effects


References